| RS118203709 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203711 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203712 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |
| RS118203717 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203724 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203726 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203727 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS118203728 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS118203732 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203733 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203735 |
TSC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203742 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS118203745 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203751 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Lymphangiomyomatosis |
| RS118203753 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS118203888 |
MT-TS2
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, cataract |
| RS118203899 |
LAMC2
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa |
| RS118203900 |
LAMC2
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 3B |
| RS118203901 |
LAMC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa, Epidermolysis bullosa |
| RS118203903 |
GIGYF2
|
Health Risk |
risk factor |
Parkinson disease 11, autosomal dominant |
| RS118203904 |
GIGYF2
|
Health Risk |
risk factor |
Parkinson disease 11, autosomal dominant |
| RS118203905 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor V Hong Kong, Thrombophilia due to activated protein C resistance |
| RS118203906 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to activated protein C resistance, Congenital factor V deficiency |
| RS118203907 |
F5
|
Health Risk |
Pathogenic/Likely pathogenic |
Factor V deficiency, Congenital factor V deficiency |
| RS118203908 |
F5
|
Health Risk |
Pathogenic |
Factor V deficiency, Factor V deficiency |
| RS118203909 |
F5
|
Health Risk |
Pathogenic |
Factor V deficiency, Factor V deficiency |
| RS118203910 |
F5
|
Health Risk |
Likely pathogenic |
Factor V deficiency, Factor V deficiency |
| RS118203911 |
F5
|
Health Risk |
Pathogenic |
Thrombophilia due to activated protein C resistance, Thrombophilia due to activated protein C resistance |
| RS118203912 |
F5
|
Health Risk |
Pathogenic |
Thrombophilia due to activated protein C resistance, Thrombophilia due to activated protein C resistance |
| RS118203913 |
RFT1
|
Health Risk |
Pathogenic/Likely pathogenic |
RFT1-congenital disorder of glycosylation, RFT1-congenital disorder of glycosylation |
| RS118203914 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS118203915 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS118203916 |
TAT
|
Health Risk |
Pathogenic |
Tyrosinemia type II, Tyrosinemia type II |
| RS118203917 |
FASTKD2
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS118203918 |
CILK1
|
Health Risk |
Pathogenic |
Endocrine-cerebro-osteodysplasia syndrome, Endocrine-cerebro-osteodysplasia syndrome |
| RS1182039209 |
IFNAR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS118203921 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS118203923 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS118203925 |
PAH
|
Health Risk |
Likely pathogenic |
Hyperphenylalaninemia, Phenylketonuria |
| RS118203929 |
NDUFAF5
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS118203931 |
CA2
|
Health Risk |
Pathogenic |
CARBONIC ANHYDRASE II VARIANT, CARBONIC ANHYDRASE II VARIANT |
| RS118203932 |
CA2
|
Health Risk |
Pathogenic |
CARBONIC ANHYDRASE II VARIANT, CARBONIC ANHYDRASE II VARIANT |
| RS118203933 |
CA2
|
Health Risk |
Pathogenic |
Osteopetrosis with renal tubular acidosis, Osteopetrosis with renal tubular acidosis |
| RS118203934 |
CA2
|
Health Risk |
Pathogenic |
Osteopetrosis with renal tubular acidosis, Osteopetrosis with renal tubular acidosis |
| RS118203935 |
CYP4F22
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 5, Lamellar ichthyosis |
| RS118203936 |
CYP4F22
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 5, Autosomal recessive congenital ichthyosis 5 |
| RS118203937 |
CYP4F22
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 5, Lamellar ichthyosis |
| RS118203939 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, type vi |
| RS118203940 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, type vi |
| RS118203941 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, type vi |
| RS118203942 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS118203943 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Metachromatic leukodystrophy |
| RS118203944 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS118203945 |
UBIAD1
|
Health Risk |
Pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS118203946 |
UBIAD1
|
Health Risk |
Pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS118203947 |
UBIAD1
|
Health Risk |
Pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS118203948 |
UBIAD1
|
Health Risk |
Pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS118203949 |
UBIAD1
|
Health Risk |
Pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS118203950 |
UBIAD1
|
Health Risk |
Pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS118203951 |
UBIAD1
|
Health Risk |
Pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS118203952 |
UBIAD1
|
Health Risk |
Pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS118203953 |
UBIAD1
|
Health Risk |
Pathogenic |
Schnyder crystalline corneal dystrophy, Schnyder crystalline corneal dystrophy |
| RS118203955 |
PDSS2
|
Health Risk |
Pathogenic |
Coenzyme Q10 deficiency, primary |
| RS118203956 |
PDSS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Coenzyme Q10 deficiency, primary |
| RS118203957 |
MARVELD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Autosomal recessive nonsyndromic hearing loss 49 |
| RS118203958 |
STRA6
|
Health Risk |
Likely pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS118203960 |
STRA6
|
Health Risk |
Pathogenic/Likely pathogenic |
Matthew-Wood syndrome, STRA6-related disorder |
| RS118203961 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS118203963 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Charcot-Marie-Tooth disease axonal type 2X |
| RS118203964 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease IIIa, Glycogen storage disease IIIa |
| RS118203965 |
CHMP4B
|
Health Risk |
Pathogenic |
Cataract 31 multiple types, Cataract 31 multiple types |
| RS118203966 |
CHMP4B
|
Health Risk |
Pathogenic |
Cataract 31 multiple types, Cataract 31 multiple types |
| RS118203967 |
PSAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
PSAT deficiency, Neu-Laxova syndrome 2 |
| RS118203968 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS118203969 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS118203970 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS118203971 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS118203972 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease type 4 |
| RS118203973 |
FGD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease type 4H |
| RS118203974 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease type 4 |
| RS118203975 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS118203976 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS118203977 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Macular dystrophy with central cone involvement |
| RS118203978 |
MFSD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis |
| RS118203979 |
CLDN19
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal hypomagnesemia 5 with ocular involvement, CLDN19-related disorder |
| RS118203980 |
CLDN19
|
Health Risk |
Pathogenic |
Renal hypomagnesemia 5 with ocular involvement, Renal hypomagnesemia 5 with ocular involvement |
| RS118203981 |
CLDN19
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal hypomagnesemia 5 with ocular involvement, Renal hypomagnesemia 5 with ocular involvement |
| RS118203982 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS118203983 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS118203984 |
ALDH5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS118203985 |
ADAMTSL4
|
Health Risk |
Pathogenic |
Ectopia lentis 2, isolated |
| RS118203988 |
PJVK
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 59, Autosomal recessive nonsyndromic hearing loss 59 |
| RS118203989 |
PJVK
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 59, Rare genetic deafness |
| RS118203990 |
TRMU
|
Health Risk |
Pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Aminoglycoside-induced deafness |
| RS118203991 |
TRMU
|
Health Risk |
Pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS118203992 |
TRMU
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS118203993 |
ORAI1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to ORAI1 deficiency, Combined immunodeficiency due to ORAI1 deficiency |
| RS118203994 |
DOK7
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 10, Congenital myasthenic syndrome |
| RS118203995 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS118203996 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |